The story of Viagra and its influence on the pharmaceutical sector presents a challenging question regarding its continued attractiveness as an investment. Initially a phenomenal success, generating huge sums , generic competition has substantially eroded financial returns. While major pharmaceutical firms hold patents on related therapies and inve

The outlook of companies tied to iconic drugs like Viagra presents a challenging investment scenario . While the initial surge of copyright, fueled by Viagra's unprecedented popularity, generated substantial wealth , the expiry in key markets has introduced considerable risk . Investors are now assessing the impact of generic competition , shrinkin